ReviewFrontiers in pharmacology2026

Beyond diabetes and obesity: GLP-1 receptor agonists as multifunctional therapeutics across the steatotic liver disease spectrum.

Sundararajan Mahalingam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.